Matches in SemOpenAlex for { <https://semopenalex.org/work/W1600221211> ?p ?o ?g. }
Showing items 1 to 82 of
82
with 100 items per page.
- W1600221211 endingPage "166" @default.
- W1600221211 startingPage "161" @default.
- W1600221211 abstract "Human erythropoietin (EPO) is a glycoprotein that enhances red blood cell production by stimulating proliferation and differentiation of erythroid progenitor cells in the bone marrow. Patients with chronic kidney disease (CKD) suffer from anemia caused by reduced production of EPO in the kidney. Recombinant human EPO protein has been used successfully for the treatment of anemia associated with CKD. Recently, attention has been paid to the development of side effect of EPO, pure red cell aplasia (PRCA), in some patients with CKD. PRCA is a rare disorder of erythropoiesis that leads to a severe anemia due to an almost complete cessation of red blood cell production. EPO-related PRCA is caused by the production of EPO-neutralizing antibodies (Abs) that eliminate the biological activity of EPO as well as endogenous EPO in patients undergoing therapy. Since 1988, almost 200 cases worldwide have been reported with Ab-positive PRCA after receiving EPO therapeutics. The underlying mechanisms of the breaking of immune tolerance to self-EPO have been investigated. Modification of formulation, organic compounds of container closures, and route of administration has been suggested for the possible mechanism of increased immunogenicity of EPO. A number of assays have been used to detect Abs specific to EPO. These assays are generally grouped into two major categories: binding Ab assays and neutralizing Ab assays (bioassays). There are several types of binding Ab assays, including radioimmunoprecipitation assay, enzyme-linked immunosorbent assay, and the BIAcore biosensor assay. In vitro cellbased bioassays have been utilized for the detection of neutralizing Abs. Finally, the recent experience with anti-EPO Abs may have considerable implications for the future development and approval of EPO preparations. Also, considering that millions of patients are being treated with EPO, clinicians need to be aware of signs and consequences of this rare but severe clinical case." @default.
- W1600221211 created "2016-06-24" @default.
- W1600221211 creator A5048637818 @default.
- W1600221211 creator A5050477010 @default.
- W1600221211 creator A5058977612 @default.
- W1600221211 creator A5069021637 @default.
- W1600221211 creator A5084283705 @default.
- W1600221211 date "2009-06-01" @default.
- W1600221211 modified "2023-09-23" @default.
- W1600221211 title "Immunogenicity of Recombinant Human Erythropoietin" @default.
- W1600221211 cites W1656818765 @default.
- W1600221211 hasPublicationYear "2009" @default.
- W1600221211 type Work @default.
- W1600221211 sameAs 1600221211 @default.
- W1600221211 citedByCount "7" @default.
- W1600221211 crossrefType "journal-article" @default.
- W1600221211 hasAuthorship W1600221211A5048637818 @default.
- W1600221211 hasAuthorship W1600221211A5050477010 @default.
- W1600221211 hasAuthorship W1600221211A5058977612 @default.
- W1600221211 hasAuthorship W1600221211A5069021637 @default.
- W1600221211 hasAuthorship W1600221211A5084283705 @default.
- W1600221211 hasConcept C104317684 @default.
- W1600221211 hasConcept C126322002 @default.
- W1600221211 hasConcept C159654299 @default.
- W1600221211 hasConcept C203014093 @default.
- W1600221211 hasConcept C2776557347 @default.
- W1600221211 hasConcept C2777422296 @default.
- W1600221211 hasConcept C2778248108 @default.
- W1600221211 hasConcept C2778534260 @default.
- W1600221211 hasConcept C2779703530 @default.
- W1600221211 hasConcept C2780868878 @default.
- W1600221211 hasConcept C40767141 @default.
- W1600221211 hasConcept C55493867 @default.
- W1600221211 hasConcept C71924100 @default.
- W1600221211 hasConcept C86803240 @default.
- W1600221211 hasConcept C98274493 @default.
- W1600221211 hasConceptScore W1600221211C104317684 @default.
- W1600221211 hasConceptScore W1600221211C126322002 @default.
- W1600221211 hasConceptScore W1600221211C159654299 @default.
- W1600221211 hasConceptScore W1600221211C203014093 @default.
- W1600221211 hasConceptScore W1600221211C2776557347 @default.
- W1600221211 hasConceptScore W1600221211C2777422296 @default.
- W1600221211 hasConceptScore W1600221211C2778248108 @default.
- W1600221211 hasConceptScore W1600221211C2778534260 @default.
- W1600221211 hasConceptScore W1600221211C2779703530 @default.
- W1600221211 hasConceptScore W1600221211C2780868878 @default.
- W1600221211 hasConceptScore W1600221211C40767141 @default.
- W1600221211 hasConceptScore W1600221211C55493867 @default.
- W1600221211 hasConceptScore W1600221211C71924100 @default.
- W1600221211 hasConceptScore W1600221211C86803240 @default.
- W1600221211 hasConceptScore W1600221211C98274493 @default.
- W1600221211 hasIssue "2" @default.
- W1600221211 hasLocation W16002212111 @default.
- W1600221211 hasOpenAccess W1600221211 @default.
- W1600221211 hasPrimaryLocation W16002212111 @default.
- W1600221211 hasRelatedWork W127258684 @default.
- W1600221211 hasRelatedWork W154039695 @default.
- W1600221211 hasRelatedWork W1656818765 @default.
- W1600221211 hasRelatedWork W2005661115 @default.
- W1600221211 hasRelatedWork W2037572532 @default.
- W1600221211 hasRelatedWork W2047040150 @default.
- W1600221211 hasRelatedWork W2052113085 @default.
- W1600221211 hasRelatedWork W2056322471 @default.
- W1600221211 hasRelatedWork W2058930880 @default.
- W1600221211 hasRelatedWork W2061804681 @default.
- W1600221211 hasRelatedWork W2103143319 @default.
- W1600221211 hasRelatedWork W2164611031 @default.
- W1600221211 hasRelatedWork W2372024088 @default.
- W1600221211 hasRelatedWork W2374028560 @default.
- W1600221211 hasRelatedWork W2395418823 @default.
- W1600221211 hasRelatedWork W2419148107 @default.
- W1600221211 hasRelatedWork W3081733386 @default.
- W1600221211 hasRelatedWork W8068029 @default.
- W1600221211 hasRelatedWork W944391025 @default.
- W1600221211 hasRelatedWork W2875717987 @default.
- W1600221211 hasVolume "15" @default.
- W1600221211 isParatext "false" @default.
- W1600221211 isRetracted "false" @default.
- W1600221211 magId "1600221211" @default.
- W1600221211 workType "article" @default.